IDEXX Laboratories Inc. (IDXX) reported fourth quarter net income of $0.67 per share Friday morning, compared to $0.62 per share in the previous year. The consensus estimate was for EPS of $0.63. Full year 2012 EPS is now expected to be between $3.04 and $3.10, compared to prior expectations of $3.00 to $3.10. The consensus estimate is for EPS of $3.07.
Shares of IDEXX Laboratories gapped open lower Friday and have since sharply declined on above average volume. The stock is now down 5.10 at $82.21 and is pulling back from resistance at the highs of the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.